NO943399L - Laksativpreparater - Google Patents

Laksativpreparater

Info

Publication number
NO943399L
NO943399L NO943399A NO943399A NO943399L NO 943399 L NO943399 L NO 943399L NO 943399 A NO943399 A NO 943399A NO 943399 A NO943399 A NO 943399A NO 943399 L NO943399 L NO 943399L
Authority
NO
Norway
Prior art keywords
laxative
manufacture
steps
dosage unit
dispersion
Prior art date
Application number
NO943399A
Other languages
English (en)
Norwegian (no)
Other versions
NO943399D0 (no
Inventor
Adrian Brown
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Ronald Brown Miller
Derek Allan Prater
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO943399D0 publication Critical patent/NO943399D0/no
Publication of NO943399L publication Critical patent/NO943399L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO943399A 1993-09-14 1994-09-13 Laksativpreparater NO943399L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9318950A GB2281697A (en) 1993-09-14 1993-09-14 Laxative compositions in capsules

Publications (2)

Publication Number Publication Date
NO943399D0 NO943399D0 (no) 1994-09-13
NO943399L true NO943399L (no) 1995-03-15

Family

ID=10741930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943399A NO943399L (no) 1993-09-14 1994-09-13 Laksativpreparater

Country Status (16)

Country Link
US (1) US5525355A (es)
EP (1) EP0642786B1 (es)
JP (1) JP3904617B2 (es)
KR (1) KR950007840A (es)
AT (1) ATE137961T1 (es)
AU (1) AU678589B2 (es)
CA (1) CA2131929A1 (es)
DE (1) DE69400189T2 (es)
ES (1) ES2091093T3 (es)
FI (1) FI944223A (es)
GB (1) GB2281697A (es)
HU (1) HUT75461A (es)
IN (1) IN178010B (es)
NO (1) NO943399L (es)
TW (1) TW354763B (es)
ZA (1) ZA946481B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2289624B (en) * 1994-05-19 1998-03-18 Euro Celtique Sa Laxative compositions
US5811125A (en) * 1996-08-30 1998-09-22 Galat; Alexander Natural laxative
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
WO2000067747A1 (en) * 1999-05-06 2000-11-16 Warner-Lambert Company Docusate hard gelatin capsules
CN1529587B (zh) 2001-05-30 2010-05-12 欧洲凯尔特公司 含有粪便软化剂泊洛沙姆和包有肠溶衣的比沙可定颗粒的药物组合物
JP4381805B2 (ja) * 2001-07-02 2009-12-09 メリオン リサーチ スリー リミテッド 生物活性材料の送達
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
KR100958892B1 (ko) * 2007-12-27 2010-05-20 한미약품 주식회사 대변 연화제 및 계면활성제를 함유하는 예비농축액

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE298351C (es) * 1915-04-09
FR1591573A (es) * 1968-05-10 1970-05-04
GB1212119A (en) * 1968-12-20 1970-11-11 Bristol Myers Co Fecal softener
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
AU476166B2 (en) * 1973-07-27 1976-08-26 Ici Australia Limited Feed supplement blocks for the treatment of bloat
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
CA1051776A (en) * 1974-08-09 1979-04-03 Murray W. Winicov Poloxamer-iodine gel
GB1604622A (en) * 1977-05-31 1981-12-09 Stafford Miller Ltd Use of polyoxyethylene derivatives as ectoparasiticides
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
NL7800268A (en) * 1978-01-09 1979-07-11 Kali Chemie Pharma Gmbh Medicament compsns. with good resorption properties - comprising solns. or suspensions in partial glyceride(s)
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
DE2850058A1 (de) * 1978-11-18 1980-05-29 Bayer Ag Polyaether-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
ZA845180B (en) * 1983-07-07 1986-02-26 American Home Prod Pharmaceutical composition containing a liquid lubricant
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
DE3673789D1 (de) * 1985-06-24 1990-10-04 Ici Australia Ltd Einnehmbare kapseln.
EP0231356A1 (en) * 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
EP0502554A3 (en) * 1986-05-15 1993-03-10 Emory University Composition comprising an oxygen radical scavenger and a surfaceactive copolymer
US4828842A (en) * 1986-09-16 1989-05-09 L. Perrigo Company Water dispersible compound
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB8701332D0 (en) * 1987-01-21 1987-02-25 Lilly Industries Ltd Capsule filling
WO1988006038A1 (en) * 1987-02-20 1988-08-25 Emory University Antiinfective compounds and method of use
US4810707A (en) * 1987-02-25 1989-03-07 Meditech Pharmaceuticals, Inc. Herpes simplex treatment
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
JPS6483016A (en) * 1987-09-25 1989-03-28 Arakawa Chem Ind Regulator for motile function of gastrointestinal tract
US4861591A (en) * 1987-11-18 1989-08-29 American Home Products Corporation Formulations for hygroscopic pharmaceuticals
DE3818022C2 (de) * 1988-05-24 1994-04-28 Guenter Stephan Weichgelatinekapsel
LU87233A1 (fr) * 1988-06-07 1990-02-28 Pharlyse Sa Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
DE59009781D1 (de) * 1989-05-16 1995-11-23 Puetter Medice Chem Pharm Verfahren zur Herstellung optisch aktiver 2-Aryl-Alkansäuren, insbesondere von 2-Aryl-Propionsäuren.
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
DK0487575T3 (da) * 1989-08-17 1994-11-28 Cortecs Ltd Farmaceutiske formuleringer
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
EP0462066A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphous gemfibrozil
JP2932086B2 (ja) * 1990-07-05 1999-08-09 高田製薬株式会社 新規なピコスルファートナトリウム液充填硬カプセル剤
US5167959A (en) * 1990-11-02 1992-12-01 Marcel Chicouri Laxative compositions and a process for producing them
CH683594A5 (de) * 1991-01-24 1994-04-15 Flachsmann Ag Emil Verfahren zur Herstellung eines Pflanzenextrakt enthaltenden Masse, welche insbesondere für die Einkapselung in ein festes Umhüllungsmaterial geeignet ist.
AU1537292A (en) 1991-04-16 1992-11-17 Nippon Shinyaku Co. Ltd. Method of manufacturing solid dispersion
FR2678168B1 (fr) * 1991-06-28 1993-09-03 Rhone Poulenc Rorer Sa Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge.
US5470568A (en) * 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5281420A (en) 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
ZA933926B (en) * 1992-06-17 1994-01-03 Amgen Inc Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules

Also Published As

Publication number Publication date
AU7292794A (en) 1995-03-30
FI944223A0 (fi) 1994-09-13
JPH07165561A (ja) 1995-06-27
FI944223A (fi) 1995-03-15
ZA946481B (en) 1995-03-28
DE69400189T2 (de) 1996-11-21
TW354763B (en) 1999-03-21
NO943399D0 (no) 1994-09-13
EP0642786B1 (en) 1996-05-15
EP0642786A1 (en) 1995-03-15
AU678589B2 (en) 1997-06-05
DE69400189D1 (de) 1996-06-20
KR950007840A (ko) 1995-04-15
HUT75461A (en) 1997-05-28
ATE137961T1 (de) 1996-06-15
GB9318950D0 (en) 1993-10-27
US5525355A (en) 1996-06-11
IN178010B (es) 1997-03-01
ES2091093T3 (es) 1996-10-16
HU9402628D0 (en) 1994-11-28
JP3904617B2 (ja) 2007-04-11
CA2131929A1 (en) 1995-03-15
GB2281697A (en) 1995-03-15

Similar Documents

Publication Publication Date Title
US5807574A (en) Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
AR015812A1 (es) Proceso para producir una formulacion farmaceutica en pastillas
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
ATE57470T1 (de) Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung.
US5453283A (en) Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
NO943399D0 (no) Laksativpreparater
SE9003296L (sv) Foerfarande foer att formulera laekemedel
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
DE69609500D1 (de) Herstellung und verwendung von diacylperoxid enthaltende kompositteilchen
EP0295212A3 (en) Process for preparing a pharmaceutical composition
GB2289624B (en) Laxative compositions
GR3029916T3 (en) A pharmaceutical form for the rectal administration of pharmacologically active compounds.
AU581730B2 (en) Soft gelatine capsules and method for their production
RU2106142C1 (ru) Способ получения сердечно-сосудистого лекарственного препарата
KR850005993A (ko) 인조 대리석의 제조 방법
KR920014473A (ko) 제약학적 화합물의 미립자가 균일하게 분산 되어있는 결정형 당알콜
DE2962118D1 (en) Derivatives of 1,3-dihydro-3-(1-(2-(2,3-dihydro-1,4-benzodioxin-2-yl)2-hydroxyethyl)piperidin-4-yl)2h-indol-2-on, process for their preparation, their use as medicaments and pharmaceutical compositions containing them